|
|
Funding Sources
|
In addition to the funding for research projects offered by the Foundation, researchers may wish to pursue some of the following funding sources relevant to their focused ultrasound projects.
|
|
Shared Instrumentation Grant Program (S10) |
 |
 |
|
Written by Hannah Edelen
|
|
Tuesday, 16 February 2010 16:47 |
|
Purpose: The NCRR Shared Instrument Grant (SIG) program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instrumentation or an integrated system that costs at least $100,000. The maximum award is $600,000. Types of instruments supported include confocal and electron microscopes, biomedical imagers, mass spectrometers, DNA sequencers, biosensors, cell sorters, X-ray diffraction systems, and NMR spectrometers among others.
Key Dates:
Release/Posted Date: January 12, 2010
Opening Date: February 23, 2010
Application Due Date: March 23, 2010
http://grants.nih.gov/grants/guide/pa-files/PAR-10-082.html |
|
Last Updated ( Wednesday, 17 February 2010 11:57 )
|
|
|
Recovery Act Limited Competition: NIH Director’s Opportunity for Research in Five Thematic Areas |
|
|
|
Written by Hannah Edelen
|
|
Monday, 04 January 2010 14:45 |
|
Purpose: This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, solicits through this limited competition applications from domestic (United States) institutions/organizations proposing to develop and implement critical research innovations in one or more of the following five thematic areas:
- Applying Genomics and Other High Throughput Technologies
- Translating Basic Science Discoveries into New and Better Treatments
- Using Science to Enable Health Care Reform
- Focusing on Global Health
- Reinvigorating the Biomedical Research Community
This program is a trans-NIH effort supported by Recovery Act funds from the Office of the Director. Applicants may propose to address either a specific disease- or technology-related research question relevant to the mission of one or more participating Institutes and Centers, or propose the creation of a unique infrastructure/resource designed to accelerate scientific progress in the future.
Key Dates:
Release/Posted Date: December 28, 2009
Opening Date: February 15, 2010 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date: February 15, 2010
Application Due Date: March 15, 2010
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-10-005.html
|
|
Last Updated ( Wednesday, 17 February 2010 11:58 )
|
|
Development of Multifunctional Drug and Gene Delivery Systems (R01) |
|
|
|
Written by David Moore
|
|
Monday, 07 December 2009 12:03 |
|
Purpose: This Funding Opportunity Announcement (FOA), issued by the National Institute of Biomedical Imaging and Bioengineering and the National Heart, Lung, and Blood Institute, National Institutes of Health, encourages Research Project Grant (R01) applications from institutions/organizations that propose the engineering of novel, multifunctional drug and gene delivery systems that can target therapies toparticular cells and intracellular compartments and can monitor delivery and determine therapeutic efficacy through the integration of advanced imaging and/or sensing technologies into the delivery system. Applications should propose to develop at least one prototype system by the end of the project period. Applications that are submitted to this FOA should include investigators from both the drug/gene delivery and imaging fields. Applicants are strongly encouraged to use the Multi-PD/PI model to meet the imaging and drug/gene delivery expertise.
Key Dates:
Release/Posted Date: December 7, 2009
Opening Date: January 5, 2010 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date(s): 30 days before Application Due Dates
http://grants.nih.gov/grants/guide/pa-files/PAR-10-048.html |
|
Last Updated ( Tuesday, 09 February 2010 13:34 )
|
|
Image-Guided Drug Delivery in Cancer (R01) |
|
|
|
Written by Hannah Edelen
|
|
Thursday, 03 December 2009 10:23 |
|
This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), encourages innovative translational research in the development of quantitative in vivo imaging characterization of image-guided drug delivery (IGDD) in cancer, including characterizations of the target, delivery validation, and therapy response.
Key Dates:
Release/Posted Date: August 13, 2009
Opening Date: January 5, 2010.
Contact: Keyvan Farahani, PhD (
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
) at 301-451-2651
http://grants.nih.gov/grants/guide/pa-files/PA-09-253.html |
|
Last Updated ( Friday, 11 December 2009 14:25 )
|
|
|
|
|
|
|
|
|
Research & Training 